Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: Its role in post-translational modification of p53 and MDM2

Cell Death and Differentiation

Volumn 14, Issue 6, 2007, Pages 1106-1116

  Lee, S J ^a,b   Lim, C J ^b   Min, J K ^a   Lee, J K ^a,b   Kim, Y M ^b   Lee, J Y ^c   Won, M H ^c   Kwon, Y G ^a  

^a Yonsei University   (South Korea)

^b Kangwon National University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; NUCLEAR PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 NUCLEAR TARGETING SUBUNIT; PROTEIN BAX; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL STRESS; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DEFEROXAMINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN PHOSPHATASE 1; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MDM2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-BINDING PROTEINS; SERINE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249050483     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402111     Document Type: Article

References (39)

1. Shenolikar S, Nairn AC. Protein phosphatases: Recent progress. Adv Second Messenger Phosphoprotein Res 1991; 23: 1-121.
2. Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP et al. Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. Biochimie 2003; 8: 721-726.
3. Ceulemans H, Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 2004; 84: 1-39.
4. Andreassen PR, Lacroix FB, Villa-Moruzzi E, Margolis RL. Differential subcellular localization of protein phosphatase-1α, γ1, and ä isoforms during both interphase and mitosis in mammalian cells. J Cell Biol 1998; 141: 1207-1215.
5. Allen PB, Kwon YG, Nairn AC, Greengard P. Isolation and characterization of PNUTS, a putative protein phosphatase 1 nuclear targeting subunit. J Biol Chem 1998; 273: 4089-4095.
6. Kim YM, Watanabe T, Allen PB, Kim YM, Lee SJ, Greengard P et al. PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit. Characterization of its PP1- and RNAbinding domains and regulation by phosphorylation. J Biol Chem 2003; 278: 13819-13828.
7. Landsverk HB, Kirkhus M, Bollen M, Kuntziger T, Collas P. PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner. Biochem J 2005; 390: 709-717.
8. Semeza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 712-732.
9. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57 1009-1014.
10. Hammond EM, Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005; 331: 718-725.
11. Xu Y. Regulation of p53 responses by post-translational modifications. Cell Death Differ 2003; 10: 400-403.
12. Kubbutat MH, Ludwig RL, Ashcroft M, Vousden KH. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol Cell Biol 1998; 18: 5690-5698.
13. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299.
14. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303.
15. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275: 8945-8951.
16. Honda R, Yasuda H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 2000; 19: 1473-1476.
17. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation the molecular basis for p53 regulation. Curr Opin Cell Biol 2003; 15: 164-171.
18. Tibbetts RS, Brumbaugh KM,Williams JM, Sarkaria JN, Cliby WA, Shieh SY et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13: 152-157.
19. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, Liu Y et al. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 2006; 28: 3006-3022.
20. Haneda M, Kojima E, Nishikimi A, Hasegawa T, Nakashima I, Isobe K. Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett 2004; 567: 171-174.
21. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O et al. ATM-dependent phosphorylation of Mdm2 on serine 395: Role in p53 activation by DNA damage. Genes Dev 2001; 15: 1067-1077.
22. Baskin-Bey ES, Gores GJ. Death by association: BH3 domain-only proteins and liver injury. Am J Physiol Gastrointest Liver Physiol 2005; 289: 987-990.
23. Shacka JJ, Roth KA. Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: Therapeutic implications. Curr Drug Targets CNS Neurol Disord 2005; 4: 25-39.
24. Zhang XD, Gillespie SK, Borrow JM, Hersey P. The histone deacetylase inhibitor suberic bishydroxamate: A potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. Biochem Pharmacol 2003; 66: 1537-1545.
25. Appella E, Anderson CW. Signaling to p53: Breaking the posttranslational modification code. Pathol Biol (Paris) 2000; 48: 227-245.
26. Kar S, Sakaguchi K, Shimohigashi Y, Samaddar S, Banerjee R, Basu G et al. Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem 2002; 277: 15579-15585.
27. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 2000; 275: 8945-8951.
28. Geyer RK, Yu ZK, Maki CG. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2000; 2: 569-573.
29. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumour suppressor p53. FEBS Lett 1997; 420: 25-27.
30. Honda R, Yasuda H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 2000; 19: 1473-1476.
31. Meek DW, Knippschild U. Posttranslational modification of MDM2. Mol Cancer Res 2003; 14: 1017-1026.
32. Sakaguchi K. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 2000; 275: 9278-9283.
33. Schon O, Friedler A, Bycroft M, Freund SM, Fersht AR. Molecular mechanism of the interaction between MDM2 and p53. J Mol Biol 2002; 323: 491-501.
34. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-1245.
35. Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 1998; 17: 554-564.
36. Deb SP. Function and dysfunction of the human oncoprotein MDM2. Front Biosci 2002; 7: 235-243.
37. Haneda M, Kojima E, Nishikimi A, Hasegawa T, Nakashima I, Isobe K. Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53. FEBS Lett 2004; 567: 171-174.
38. Hammond EM, Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005; 331: 718-725.
39. Iida T, Mine S, Fujimoto H, Suzuki K, Minami Y, Tanaka Y. Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells. Genes Cells 2002; 7: 143-149.